Article Information
History
- March 22, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Chia-En Lien1,2,
- Tsun-Yung Kuo1,3,
- Yi-Jiun Lin1,
- Wei-Cheng Lian1,
- Meei-Yun Lin1,
- Luke Tzu-Chi Liu1,
- Yu-Chi Chou4 and
- Charles Chen1,5,*
- 1Medigen Vaccine Biologics Corporation, Taipei City, Taiwan
- 2Institute of Public Health, National Yang-Ming Chiao Tung University, Taiwan
- 3Department of Biotechnology and Animal Science, National Ilan University, Yilan County, Taiwan
- 4Biomedical Translation Research Center (BioTReC), Academia Sinica
- 5Temple University, Philadelphia, PA 19122, USA
- ↵*Corresponding author: charles{at}medigenvac.com